Related Experiment Video
Updated: May 5, 2026

Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer
Published on: August 2, 2024
Cisplatin, oxaliplatin, and carboplatin unequally inhibit in vitro mRNA translation
Jonas Philipp Becker1, Johanna Weiss1, Dirk Theile1
1Department of Clinical Pharmacology and Pharmacoepidemiology, University of Heidelberg, Im Neuenheimer Feld 410, 69120 Heidelberg, Germany.
Abstract:
DNA is considered the preferential target of platinum containing cytostatics such as cisplatin, oxaliplatin, and carboplatin. Despite profound knowledge on the interaction between platinum drugs and DNA, there is little data on the interaction with mRNA and even less on the potential differences among these antineoplastic agents to inhibit protein synthesis. We therefore established an in vitro translation system using in vitro transcribed mRNA encoding green fluorescent protein (GFP) to evaluate the effects of exposure of GFP mRNA to 0-100 μM of cisplatin, oxaliplatin, or carboplatin. We additionally investigated the interaction between these drugs and mRNA through evaluation of crossing-points during quantitative real-time polymerase chain reactions. In contrast to oxaliplatin or carboplatin, 100 μM cisplatin significantly increased crossing-points by about 3 cycles (P<0.01) and profoundly attenuated translation of GFP mRNA (P<0.05). Oxaliplatin showed a trend to reduce GFP mRNA translation, whereas carboplatin entirely failed to influence it. In conclusion, this study for the very first time documents different effects of platinum cytostatics on mRNA translation and demonstrates mRNA to be a functionally relevant target of at least cisplatin.
Insights
Platinum drugs like cisplatin can impact protein synthesis by affecting messenger RNA (mRNA). This study shows cisplatin, but not oxaliplatin or carboplatin, significantly inhibits mRNA translation, revealing mRNA as a functional target.
Area of Science:
- Biochemistry
- Molecular Biology
- Pharmacology
Background:
- Platinum-based chemotherapy agents, including cisplatin, oxaliplatin, and carboplatin, are known to target DNA.
- Limited research exists on the interaction of these platinum drugs with messenger RNA (mRNA) and their differential effects on protein synthesis inhibition.
Purpose of the Study:
- To investigate the effects of cisplatin, oxaliplatin, and carboplatin on mRNA translation in vitro.
- To determine if mRNA is a functional target for platinum-based antineoplastic agents.
Main Methods:
- An in vitro translation system was established using mRNA encoding green fluorescent protein (GFP).
- GFP mRNA was exposed to varying concentrations (0-100 μM) of cisplatin, oxaliplatin, or carboplatin.
- Drug-mRNA interactions were assessed by monitoring crossing-points in quantitative real-time polymerase chain reactions (qRT-PCR).
- The impact on protein synthesis was evaluated by measuring GFP translation.
Main Results:
- Cisplatin (100 μM) significantly increased qRT-PCR crossing-points and markedly reduced GFP mRNA translation.
- Oxaliplatin exhibited a trend towards reduced GFP mRNA translation.
- Carboplatin did not significantly affect GFP mRNA translation.
Conclusions:
- This study provides the first evidence of differential effects of platinum cytostatics on mRNA translation.
- Messenger RNA (mRNA) is demonstrated to be a functionally relevant target for at least cisplatin.
- The findings suggest distinct mechanisms of action for platinum-based drugs beyond DNA interaction.
More Related Videos
Related Concept Videos
Inhibitors of Bacterial Protein Synthesis
Drugs that Destabilize Microtubules
MicroRNAs
MicroRNAs
Regulation of Expression at Multiple Steps
Riboswitches
The aptamer has high specificity for a particular metabolite which allows riboswitches to specifically regulate...

